Who listened to PS Targeting IP asset to Avid Bioservices CDMO CEO Laura Benjamin yet? ...27 minutes .. longer than the Avid BOD boys can talk and makes John Springs Stafford sound a bit foolish, now....he must have been working for some other party.
She speaks openly about the IP assets and more : ) ....someone today must have realized this info is getting out to NEW IIS
Laura Benjamin at the end of the interview...just admitted Bavituximab treated patients are LIVING longer : )
She called the other IP asset to Avid CDMO where royalties will come and manufacturing ...a best in class VEGF
John Stafford lied, stole and helped shift the IP to Oncologie ...didn't he ?
Dr Benjamin verified she will be presenting at SITC 2019 and ALL good words she spoke of the IP assets
Congratulations to extended MOS to Merck Keytruda patents ....as it was Bavituximab that allowed for the MOS survival, NOT Keytruda